Why Neuronetics, Inc.’s (STIM) Stock Is Up 15.93%
As of Wednesday, November 04, Neuronetics, Inc.’s STIM share price has surged by 15.93%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Commentary & Analysis
Why Neuronetics, Inc.’s (STIM) Stock Is Up 6.80%
As of Tuesday, November 03, Neuronetics, Inc.’s STIM share price has surged by 6.80%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Neuronetics, Inc.’s (STIM) Stock Is Down 8.08%
As of Friday, October 30, Neuronetics, Inc.’s STIM share price has dipped by 8.08%, which has investors questioning if this is right time to buy.Michael Rose
Why Neuronetics, Inc.’s (STIM) Stock Is Up 6.42%
As of Thursday, October 29, Neuronetics, Inc.’s STIM share price has surged by 6.42%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Neuronetics, Inc.’s (STIM) Stock Is Up 5.69%
As of Monday, October 26, Neuronetics, Inc.’s STIM share price has surged by 5.69%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | STIM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $206.1 | $437.4 | 28% |
|
| Shares Out (Mil) | 73.1 | 40.7 | 56% |
|
| Institutional Ownership | 55.3% | 83.6% | 37% |
|
| Float (Mil) | 37.1 | 35.5 | 40% |
|
| Beta | 1.17 | 0.85 | 69% |
|
| Avg Daily Volume (000s) | 1,326 | 333 | 74% |
|
| Price Change (52-week) |
(2.4%) | 68.1% | 46% |
|
| Growth | STIM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 24.8% | 11.8% | 86% |
|
| Net Income (5yr) | (7.2%) | (5.7%) | 32% |
|
| EPS (5yr) | 16.5% | 10.6% | 61 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 16.6% | (15.6%) | 75% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.110) | ($0.470) | ($0.340) | |
| Month Ago EPS | ($0.110) | ($0.470) | ($0.340) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 2 | |
| Three Months Ago EPS | ($0.113) | ($0.465) | ($0.338) | |
| Year/Year Chg | 134.0% | (20.5%) | (52.6%) | |
| Financials | STIM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $155 | $141 | 30% |
|
| Net Income (TTM) (Mil) | ($30) | ($9) | 20% |
|
| EPS (TTM) | ($0.437) | ($0.400) | 28% |
|
| Operating Cash Flow (TTM) (Mil) | ($10) | ($1) | 20% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $1 | 55% |
|
| Long-Term Debt (Q1) (Mil) | $81 | $27 | 43% |
|
| Enterprise Value (Q1) (Mil) | $292 | $381 | 29% |
|
| Valuation | STIM | Industry Median |
Percentile (All Stocks) |
|
| P/B | 11.76 | 2.62 | 93% |
|
| P/E | na | 30.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | STIM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 49.4% | 59.0% | 61% |
|
| Net Margin | (19.6%) | (6.6%) | 17% |
|
| ROA | (22.9%) | (11.3%) | 19% |
|
| ROE | (135.3%) | (10.1%) | 7% |
|
| Liabilities to Assets | 83.5% | 47.1% | 78% |
|
| F-Score | 4 | 4 | 33% |
|
Neuronetics, Inc. did not pass any screens on 11/4/2026.
